{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:11:44Z","timestamp":1773285104766,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00428-020-02788-7","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T18:03:01Z","timestamp":1583776981000},"page":"437-444","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Classic Hodgkin lymphoma and Castleman disease: an entity appears to be emerging"],"prefix":"10.1007","volume":"477","author":[{"given":"Kirill A.","family":"Lyapichev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. James","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Vega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa M.","family":"Solis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,9]]},"reference":[{"key":"2788_CR1","unstructured":"Swerdlow SH, Campo E, Harris LH, Jaffe ES, Pileri SA, Stein H, Thiele J (2017) WHO classification of tumours of haematopoietic and lymphoid tissues (Revised 4th Edition). IARC: Lyon 2017"},{"issue":"1","key":"2788_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.hoc.2017.09.002","volume":"32","author":"DC Fajgenbaum","year":"2018","unstructured":"Fajgenbaum DC, Shilling D (2018) Castleman disease pathogenesis. Hematol Oncol Clin North Am 32(1):11\u201321. https:\/\/doi.org\/10.1016\/j.hoc.2017.09.002","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"2788_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/00000478-198303000-00004","volume":"7","author":"RS Doggett","year":"1983","unstructured":"Doggett RS, Colby TV, Dorfman RF (1983) Interfollicular Hodgkin\u2019s disease. Am J Surg Pathol 7(2):145\u2013149. https:\/\/doi.org\/10.1097\/00000478-198303000-00004","journal-title":"Am J Surg Pathol"},{"issue":"13","key":"2788_CR4","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1056\/NEJM199009273231308","volume":"323","author":"D Cros","year":"1990","unstructured":"Cros D, Harris NL, Wedley-Whyte ET (1990) Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 39\u20131990. A 66-year-old man with demyelinative neuropathy and a retroperitoneal mass. N Engl J Med 323(13):895\u2013908. https:\/\/doi.org\/10.1056\/NEJM199009273231308","journal-title":"N Engl J Med"},{"issue":"3","key":"2788_CR5","first-page":"273","volume":"33","author":"P Brice","year":"1991","unstructured":"Brice P, Marolleau JP, D\u2019Agay MF, Epardeau B, Gisselbrecht C (1991) Autoimmune hemolytic anemia disclosing Hodgkin\u2019s disease associated with Castleman\u2019s disease. Nouv Rev Fr Hematol 33(3):273\u2013274","journal-title":"Nouv Rev Fr Hematol"},{"issue":"3","key":"2788_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1365-2559.1991.tb00833.x","volume":"18","author":"PR Maheswaran","year":"1991","unstructured":"Maheswaran PR, Ramsay AD, Norton AJ, Roche WR (1991) Hodgkin\u2019s disease presenting with the histological features of Castleman\u2019s disease. Histopathology 18(3):249\u2013253. https:\/\/doi.org\/10.1111\/j.1365-2559.1991.tb00833.x","journal-title":"Histopathology"},{"issue":"1","key":"2788_CR7","first-page":"129","volume":"141","author":"SM Hsu","year":"1992","unstructured":"Hsu SM, Xie SS, Hsu PL, Waldron JA Jr (1992) Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin\u2019s disease with or without histologic features of Castleman\u2019s disease. Am J Pathol 141(1):129\u2013138","journal-title":"Am J Pathol"},{"issue":"3","key":"2788_CR8","first-page":"270","volume":"118","author":"A Zarate-Osorno","year":"1994","unstructured":"Zarate-Osorno A, Medeiros LJ, Danon AD, Neiman RS (1994) Hodgkin\u2019s disease with coexistent Castleman-like histologic features. A report of three cases. Arch Pathol Lab Med 118(3):270\u2013274","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"2788_CR9","first-page":"384","volume":"14","author":"V Molinie","year":"1994","unstructured":"Molinie V, Perie G, Melo I, Melo C, Audouin J, Diebold J (1994) Association of Castleman\u2019s disease and Hodgkin\u2019s disease. Eight cases and review of the literature. Ann Pathol 14(6):384\u2013391","journal-title":"Ann Pathol"},{"issue":"2","key":"2788_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s002770050482","volume":"78","author":"P Saletti","year":"1999","unstructured":"Saletti P, Ghielmini M, Scali G, Pedrinis E, Gueneau M, Cavalli F (1999) Hodgkin\u2019s and Castleman\u2019s disease in a patient with systemic mastocytosis. Ann Hematol 78(2):97\u2013100. https:\/\/doi.org\/10.1007\/s002770050482","journal-title":"Ann Hematol"},{"issue":"3","key":"2788_CR11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4038\/cmj.v45i3.8120","volume":"45","author":"SJ Hewavisenthi","year":"2000","unstructured":"Hewavisenthi SJ, Wedysinghe AN (2000) Interfollicular Hodgkin\u2019s disease with histological features of Castleman\u2019s disease. Ceylon Med J 45(3):138\u2013139. https:\/\/doi.org\/10.4038\/cmj.v45i3.8120","journal-title":"Ceylon Med J"},{"issue":"10","key":"2788_CR12","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1136\/jcp.54.10.790","volume":"54","author":"E Caussinus","year":"2001","unstructured":"Caussinus E, Meggetto F, Delsol G, Brousset P (2001) Simultaneous occurrence of Epstein-Barr virus associated Hodgkin\u2019s disease and HHV-8 related multicentric Castleman\u2019s disease: a fortuitous event? J Clin Pathol 54(10):790\u2013791. https:\/\/doi.org\/10.1136\/jcp.54.10.790","journal-title":"J Clin Pathol"},{"issue":"2","key":"2788_CR13","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/1097-0347(200102)23:2<166::aid-hed1012>3.0.co;2-p","volume":"23","author":"DK Frank","year":"2001","unstructured":"Frank DK, Charney D, Kashani A (2001) Plasma cell variant of Castleman\u2019s disease occurring concurrently with Hodgkin\u2019s disease in the neck. Head Neck 23(2):166\u2013169. https:\/\/doi.org\/10.1002\/1097-0347(200102)23:2<166::aid-hed1012>3.0.co;2-p","journal-title":"Head Neck"},{"issue":"2","key":"2788_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/ajh.10022","volume":"69","author":"C Larroche","year":"2002","unstructured":"Larroche C, Cacoub P, Soulier J, Oksenhendler E, Clauvel JP, Piette JC, Raphael M (2002) Castleman\u2019s disease and lymphoma: report of eight cases in HIV-negative patients and literature review. Am J Hematol 69(2):119\u2013126. https:\/\/doi.org\/10.1002\/ajh.10022","journal-title":"Am J Hematol"},{"issue":"3","key":"2788_CR15","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1365-2559.2005.02234.x","volume":"48","author":"U Zanetto","year":"2006","unstructured":"Zanetto U, Pagani FP, Perez C (2006) Interfollicular Hodgkin\u2019s lymphoma and Castleman\u2019s disease. Histopathology 48(3):317\u2013319. https:\/\/doi.org\/10.1111\/j.1365-2559.2005.02234.x","journal-title":"Histopathology"},{"issue":"5","key":"2788_CR16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1600-0609.2007.00952.x","volume":"79","author":"L Falchi","year":"2007","unstructured":"Falchi L, Capello D, Palumbo B, Rauco A, Emili R, Cianciulli M, Pace R, Capparella V, Liberati F, Liberati AM (2007) A case of nodular sclerosis Hodgkin\u2019s lymphoma repeatedly relapsing in the context of composite plasma cell-hyaline vascular Castleman\u2019s disease: successful response to rituximab and radiotherapy. Eur J Haematol 79(5):455\u2013461. https:\/\/doi.org\/10.1111\/j.1600-0609.2007.00952.x","journal-title":"Eur J Haematol"},{"issue":"6","key":"2788_CR17","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.prp.2006.12.006","volume":"203","author":"T Vasudev Rao","year":"2007","unstructured":"Vasudev Rao T, Alkindi S, Pathare AV (2007) Follicular dendritic cell hyperplasia in plasma cell variant of Castleman\u2019s disease with interfollicular Hodgkin\u2019s disease. Pathol Res Pract 203(6):479\u2013484. https:\/\/doi.org\/10.1016\/j.prp.2006.12.006","journal-title":"Pathol Res Pract"},{"issue":"2","key":"2788_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4103\/0971-5851.60052","volume":"30","author":"S Haque","year":"2009","unstructured":"Haque S, van Kirk R (2009) Three patients with both Hodgkin\u2019s lymphoma and Castleman\u2019s disease: clinicopathologic correlations and lack of association with HHV-8. Indian J Med Paediatr Oncol 30(2):76\u201379. https:\/\/doi.org\/10.4103\/0971-5851.60052","journal-title":"Indian J Med Paediatr Oncol"},{"key":"2788_CR19","doi-asserted-by":"publisher","first-page":"487205","DOI":"10.1155\/2013\/487205","volume":"2013","author":"A Mohtaram","year":"2013","unstructured":"Mohtaram A, Afif M, Sghiri T, Rami A, Latib R, Kettani F, Ben Ameur El Youbi M, Boutayeb S, Kebdani T, Benjaafar N, Aaribi I, Errihani H (2013) Coexistence of Hodgkin\u2019s lymphoma and Castleman\u2019s disease: a case report with successful response to chemotherapy and radiotherapy. Case Rep Oncol Med 2013:487205. https:\/\/doi.org\/10.1155\/2013\/487205","journal-title":"Case Rep Oncol Med"},{"issue":"2","key":"2788_CR20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s12185-013-1262-7","volume":"97","author":"A Momoi","year":"2013","unstructured":"Momoi A, Kojima M, Sakai T, Ajiro J, Isahai N, Nagai K, Aoki S (2013) IL-6-positive classical Hodgkin\u2019s lymphoma co-occurring with plasma cell type of Castleman\u2019s disease: report of a case. Int J Hematol 97(2):275\u2013279. https:\/\/doi.org\/10.1007\/s12185-013-1262-7","journal-title":"Int J Hematol"},{"key":"2788_CR21","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s12288-014-0429-6","volume":"30","author":"SK Reddy","year":"2014","unstructured":"Reddy SK, Rekha JS, Jacob SE, Basu D (2014) Diagnostic issues in a case of Hodgkin lymphoma with Castleman like features. Indian J Hematol Blood Transfus 30:386\u2013389. https:\/\/doi.org\/10.1007\/s12288-014-0429-6","journal-title":"Indian J Hematol Blood Transfus"},{"key":"2788_CR22","doi-asserted-by":"publisher","first-page":"9423205","DOI":"10.1155\/2017\/9423205","volume":"2017","author":"L Filliatre-Clement","year":"2017","unstructured":"Filliatre-Clement L, Busby-Venner H, Moulin C, Roth-Guepin G, Perrot A (2017) Hodgkin lymphoma and Castleman disease: when one blood disease can hide another. Case Rep Hematol 2017:9423205. https:\/\/doi.org\/10.1155\/2017\/9423205","journal-title":"Case Rep Hematol"},{"issue":"3","key":"2788_CR23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1182\/blood-2017-05-782128","volume":"130","author":"S Gong","year":"2017","unstructured":"Gong S, Hijiya N (2017) Classical Hodgkin lymphoma and Castleman disease: a rare morphologic combination. Blood 130(3):381. https:\/\/doi.org\/10.1182\/blood-2017-05-782128","journal-title":"Blood"},{"key":"2788_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.anndiagpath.2017.11.009","volume":"33","author":"B AbdullGaffar","year":"2018","unstructured":"AbdullGaffar B, Seliem RM (2018) Hodgkin lymphoma with an interfollicular growth pattern: a clinicopathologic study of 8 cases. Ann Diagn Pathol 33:30\u201334. https:\/\/doi.org\/10.1016\/j.anndiagpath.2017.11.009","journal-title":"Ann Diagn Pathol"},{"issue":"11","key":"2788_CR25","first-page":"1755","volume":"31","author":"RJ Lukes","year":"1971","unstructured":"Lukes RJ (1971) Criteria for involvement of lymph node, bone marrow, spleen, and liver in Hodgkin\u2019s disease. Cancer Res 31(11):1755\u20131767","journal-title":"Cancer Res"},{"issue":"4","key":"2788_CR26","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/1097-0142(195607\/08)9:4<822::aid-cncr2820090430>3.0.co;2-4","volume":"9","author":"B Castleman","year":"1956","unstructured":"Castleman B, Iverson L, Menendez VP (1956) Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer 9(4):822\u2013830. https:\/\/doi.org\/10.1002\/1097-0142(195607\/08)9:4<822::aid-cncr2820090430>3.0.co;2-4","journal-title":"Cancer"},{"issue":"3","key":"2788_CR27","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/1097-0142(197203)29:3<670::aid-cncr2820290321>3.0.co;2-#","volume":"29","author":"AR Keller","year":"1972","unstructured":"Keller AR, Hochholzer L, Castleman B (1972) Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 29(3):670\u2013683. https:\/\/doi.org\/10.1002\/1097-0142(197203)29:3<670::aid-cncr2820290321>3.0.co;2-#","journal-title":"Cancer"},{"issue":"5","key":"2788_CR28","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.3109\/10428194.2014.953145","volume":"56","author":"N Munshi","year":"2015","unstructured":"Munshi N, Mehra M, van de Velde H, Desai A, Potluri R, Vermeulen J (2015) Use of a claims database to characterize and estimate the incidence rate for Castleman disease. Leuk Lymphoma 56(5):1252\u20131260. https:\/\/doi.org\/10.3109\/10428194.2014.953145","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"2788_CR29","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.path.2019.03.003","volume":"12","author":"W Wang","year":"2019","unstructured":"Wang W, Medeiros LJ (2019) Castleman disease. Surg Pathol Clin 12(3):849\u2013863. https:\/\/doi.org\/10.1016\/j.path.2019.03.003","journal-title":"Surg Pathol Clin"},{"issue":"1","key":"2788_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.hoc.2017.09.003","volume":"32","author":"K Yoshizaki","year":"2018","unstructured":"Yoshizaki K, Murayama S, Ito H, Koga T (2018) The role of interleukin-6 in Castleman disease. Hematol Oncol Clin North Am 32(1):23\u201336. https:\/\/doi.org\/10.1016\/j.hoc.2017.09.003","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"2788_CR31","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1182\/blood.V74.4.1360.1360","volume":"74","author":"K Yoshizaki","year":"1989","unstructured":"Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K, Nakahata T, Kawai H, Tagoh H, Komori T et al (1989) Pathogenic significance of interleukin-6 (IL-6\/BSF-2) in Castleman\u2019s disease. Blood 74(4):1360\u20131367","journal-title":"Blood"},{"issue":"3","key":"2788_CR32","first-page":"183","volume":"2","author":"O Devergne","year":"1991","unstructured":"Devergne O, Peuchmaur M, Humbert M, Navratil E, Leger-Ravet MB, Crevon MC, Petit MA, Galanaud P, Emilie D (1991) In vivo expression of IL-1 beta and IL-6 genes during viral infections in human. Eur Cytokine Netw 2(3):183\u2013194","journal-title":"Eur Cytokine Netw"},{"issue":"5","key":"2788_CR33","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/leu.2015.341","volume":"30","author":"WJ Chng","year":"2016","unstructured":"Chng WJ, Chung TH, Kumar S, Usmani S, Munshi N, Avet-Loiseau H, Goldschmidt H, Durie B, Sonneveld P (2016) Gene signature combinations improve prognostic stratification of multiple myeloma patients. Leukemia 30(5):1071\u20131078. https:\/\/doi.org\/10.1038\/leu.2015.341","journal-title":"Leukemia"},{"issue":"24","key":"2788_CR34","doi-asserted-by":"publisher","first-page":"6812","DOI":"10.1158\/1078-0432.CCR-13-1879","volume":"19","author":"PR Marri","year":"2013","unstructured":"Marri PR, Hodge LS, Maurer MJ, Ziesmer SC, Slager SL, Habermann TM, Link BK, Cerhan JR, Novak AJ, Ansell SM (2013) Prognostic significance of pretreatment serum cytokines in classical Hodgkin lymphoma. Clin Cancer Res 19(24):6812\u20136819. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-1879","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2788_CR35","first-page":"1173","volume":"139","author":"H Merz","year":"1991","unstructured":"Merz H, Fliedner A, Orscheschek K, Binder T, Sebald W, Muller-Hermelink HK, Feller AC (1991) Cytokine expression in T-cell lymphomas and Hodgkin\u2019s disease. Its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth. Am J Pathol 139(5):1173\u20131180","journal-title":"Am J Pathol"},{"issue":"11","key":"2788_CR36","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1182\/blood.V77.11.2413.2413","volume":"77","author":"M Jucker","year":"1991","unstructured":"Jucker M, Abts H, Li W, Schindler R, Merz H, Gunther A, von Kalle C, Schaadt M, Diamantstein T, Feller AC et al (1991) Expression of interleukin-6 and interleukin-6 receptor in Hodgkin\u2019s disease. Blood 77(11):2413\u20132418","journal-title":"Blood"},{"key":"2788_CR37","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.humpath.2017.08.024","volume":"68","author":"S Pina-Oviedo","year":"2017","unstructured":"Pina-Oviedo S, Miranda RN, Lin P, Manning JT, Medeiros LJ (2017) Follicular lymphoma with hyaline-vascular Castleman-like features: analysis of 6 cases and review of the literature. Hum Pathol 68:136\u2013146. https:\/\/doi.org\/10.1016\/j.humpath.2017.08.024","journal-title":"Hum Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-020-02788-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-020-02788-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-020-02788-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:38:50Z","timestamp":1615250330000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-020-02788-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,9]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["2788"],"URL":"https:\/\/doi.org\/10.1007\/s00428-020-02788-7","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,9]]},"assertion":[{"value":"6 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have fulfilled all ethical standards relevant for this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}